Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Rodvold

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Developmental Pharmacology and Therapeutics|January 1, 1987
The pharmacokinetics of naloxone in the premature newbornI L Stile, M Fort, R J Wurzburger, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1994
A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patientK Vance-Bryan, J C Rotschafer, S S Gilliland, et al.
Neurology|June 1, 1984
Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic diseaseM Ramirez-Lassepas, R J Cipolle, K A Rodvold, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimensD J Occhipinti, S L Pendland, L L Schoonover, et al.
American Journal of Hospital Pharmacy|July 1, 1988
Stability of nizatidine in commonly used intravenous fluids and containersD L Raineri, M J Cwik, K A Rodvold, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1988
Vancomycin pharmacokinetics in patients with various degrees of renal functionK A Rodvold, R A Blum, J H Fischer, et al.
Pharmacotherapy|January 1, 1989
Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patientsH Z Zokufa, K A Rodvold, R A Blum, et al.
Pharmacotherapy|February 20, 1998
Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infectionsC R Messick, M Mamdani, I R McNicholl, et al.
Cancer|August 15, 1991
High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinomaD A Rushing, W R Friedenberg, M C Baldauf, et al.
Leukemia & Lymphoma|June 1, 1999
Multi-drug resistance in chronic lymphocytic leukemiaW R Friedenberg, S K Spencer, C Musser, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Developmental Pharmacology and Therapeutics|January 1, 1987
The pharmacokinetics of naloxone in the premature newbornI L Stile, M Fort, R J Wurzburger, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1994
A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patientK Vance-Bryan, J C Rotschafer, S S Gilliland, et al.
Neurology|June 1, 1984
Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic diseaseM Ramirez-Lassepas, R J Cipolle, K A Rodvold, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimensD J Occhipinti, S L Pendland, L L Schoonover, et al.
American Journal of Hospital Pharmacy|July 1, 1988
Stability of nizatidine in commonly used intravenous fluids and containersD L Raineri, M J Cwik, K A Rodvold, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1988
Vancomycin pharmacokinetics in patients with various degrees of renal functionK A Rodvold, R A Blum, J H Fischer, et al.
Pharmacotherapy|January 1, 1989
Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patientsH Z Zokufa, K A Rodvold, R A Blum, et al.
Pharmacotherapy|February 20, 1998
Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infectionsC R Messick, M Mamdani, I R McNicholl, et al.
Cancer|August 15, 1991
High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinomaD A Rushing, W R Friedenberg, M C Baldauf, et al.
Leukemia & Lymphoma|June 1, 1999
Multi-drug resistance in chronic lymphocytic leukemiaW R Friedenberg, S K Spencer, C Musser, et al.
Pageof 9